XML 48 R37.htm IDEA: XBRL DOCUMENT
v3.25.3

SEGMENT AND GEOGRAPHIC INFORMATION (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Schedule of Segment Reporting Information | Net sales and profit by each reportable segment for the three and nine months ended September 30, 2025 and 2024 are as follows:
| Three Months Ended September 30, 2025 |  | Nine Months Ended September 30, 2025
Dollars in thousands | Codman Specialty Surgical |  | Tissue Technologies |  | Corporate and Other |  | Total |  | Codman Specialty Surgical |  | Tissue Technologies |  | Corporate and Other |  | Total
Total revenue, net | $ | 292,583 |  |  | $ | 109,479 |  |  | $ | — |  |  | $ | 402,062 |  |  | $ | 877,204 |  |  | $ | 323,116 |  |  | $ | — |  |  | $ | 1,200,320 |
Cost of goods sold | 93,289 |  |  | 42,668 |  |  | 59,114 |  |  | 195,071 |  |  | 288,070 |  |  | 138,499 |  |  | 162,996 |  |  | 589,565 |
Research and development | 6,632 |  |  | 4,189 |  |  | 11,635 |  |  | 22,456 |  |  | 22,276 |  |  | 12,243 |  |  | 39,662 |  |  | 74,181 |
Selling, general & administrative | 62,433 |  |  | 35,478 |  |  | 71,135 |  |  | 169,046 |  |  | 201,309 |  |  | 110,283 |  |  | 218,841 |  |  | 530,433 |
Intangible asset amortization | — |  |  | — |  |  | 3,728 |  |  | 3,728 |  |  | — |  |  | — |  |  | 11,186 |  |  | 11,186 |
Goodwill impairment | — |  |  | — |  |  | — |  |  | — |  |  | 388,106 |  |  | 123,259 |  |  | — |  |  | 511,365 |
Total cost and expenses | 162,354 |  |  | 82,335 |  |  | 145,612 |  |  | 390,301 |  |  | 899,761 |  |  | 384,284 |  |  | 432,685 |  |  | 1,716,730 |
Operating income (loss) | $ | 130,229 |  |  | $ | 27,144 |  |  | $ | (145,612) |  |  | 11,761 |  |  | $ | (22,557) |  |  | $ | (61,168) |  |  | $ | (432,685) |  |  | (516,410) |
Interest income |  |  |  |  |  |  | 4,982 |  |  |  |  |  |  |  |  | 14,112 |
Interest expense |  |  |  |  |  |  | (22,725) |  |  |  |  |  |  |  |  | (62,582) |
Other income, net |  |  |  |  |  |  | (842) |  |  |  |  |  |  |  |  | (2,932) |
Loss before income taxes |  |  |  |  |  |  | $ | (6,824) |  |  |  |  |  |  |  |  | $ | (567,812) |
| Three Months Ended September 30, 2024 |  | Nine Months Ended September 30, 2024
Dollars in thousands | Codman Specialty Surgical |  | Tissue Technologies |  | Corporate and Other |  | Total |  | Codman Specialty Surgical |  | Tissue Technologies |  | Corporate and Other |  | Total
Total revenue, net | $ | 270,782 |  |  | $ | 110,052 |  |  | $ | — |  |  | $ | 380,834 |  |  | $ | 828,977 |  |  | $ | 338,904 |  |  | $ | — |  |  | $ | 1,167,881 |
Cost of goods sold | 95,829 |  |  | 40,529 |  |  | 44,238 |  |  | 180,596 |  |  | 281,443 |  |  | 119,512 |  |  | 133,937 |  |  | 534,892 |
Research and development | 8,548 |  |  | 4,506 |  |  | 14,381 |  |  | 27,435 |  |  | 21,880 |  |  | 13,858 |  |  | 48,429 |  |  | 84,167 |
Selling, general & administrative | 65,867 |  |  | 36,535 |  |  | 74,791 |  |  | 177,193 |  |  | 157,483 |  |  | 109,199 |  |  | 271,781 |  |  | 538,463 |
Intangible asset amortization | — |  |  | — |  |  | 3,760 |  |  | 3,760 |  |  | — |  |  | — |  |  | 17,575 |  |  | 17,575 |
Total cost and expenses | 170,244 |  |  | 81,570 |  |  | 137,170 |  |  | 388,984 |  |  | 460,806 |  |  | 242,569 |  |  | 471,722 |  |  | 1,175,097 |
Operating income (loss) | $ | 100,538 |  |  | $ | 28,482 |  |  | $ | (137,170) |  |  | (8,150) |  |  | $ | 368,171 |  |  | $ | 96,335 |  |  | $ | (471,722) |  |  | (7,216) |
Interest income |  |  |  |  |  |  | 5,049 |  |  |  |  |  |  |  |  | 15,147 |
Interest expense |  |  |  |  |  |  | (19,373) |  |  |  |  |  |  |  |  | (51,648) |
Other income, net |  |  |  |  |  |  | 2,112 |  |  |  |  |  |  |  |  | 2,939 |
Loss before income taxes |  |  |  |  |  |  | $ | (20,362) |  |  |  |  |  |  |  |  | $ | (40,778) |
Schedule of Geographic Revenue, by Area | Total revenue by major geographic area consisted of the following:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
Dollars in thousands | 2025 |  | 2024 |  | 2025 |  | 2024
United States | $ | 295,846 |  |  | $ | 290,192 |  |  | $ | 884,371 |  |  | $ | 856,646 |
Europe | 42,893 |  |  | 34,368 |  |  | 120,813 |  |  | 116,653 |
Asia Pacific | 42,680 |  |  | 37,052 |  |  | 135,517 |  |  | 132,548 |
Rest of World | 20,643 |  |  | 19,222 |  |  | 59,619 |  |  | 62,034 |
Total Revenues | $ | 402,062 |  |  | $ | 380,834 |  |  | $ | 1,200,320 |  |  | $ | 1,167,881 |

X
- Definition Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration